You are here

  • Home
  • Archive
  • Volume 99, Issue 5
  • One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD

Article metrics

Article menu
Download PDFPDF
Clinical science
One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD

 

Online download statistics by month:

Online download statistics by month: November 2014 to September 2024

AbstractFullPdf
Nov 20143683168
Dec 20141121016
Jan 2015631113
Feb 20151835
Mar 20152889
Apr 20155431762
May 20155742685
Jun 20151681014
Jul 20151201720
Aug 201576820
Sep 2015891320
Oct 2015571614
Nov 2015851220
Dec 201551719
Jan 201635811
Feb 201619512
Mar 20163827
Apr 20161853
May 20163532
Jun 201623410
Jul 201633612
Aug 20163231
Sep 20163156
Oct 20162735
Nov 201621115
Dec 20162100
Jan 20172342
Feb 20173922
Mar 20172025
Apr 201729917
May 20172535
Jun 20172765
Jul 20174484
Aug 20173520
Sep 201715222
Oct 201730755
Nov 2017114228
Dec 201784253
Jan 201869160
Feb 201867173
Mar 201852143
Apr 201840162
May 201879113
Jun 201858141
Jul 201863211
Aug 201860264
Sep 201851221
Oct 201883165
Nov 201841143
Dec 201839161
Jan 201957163
Feb 201943154
Mar 20195321
Apr 20194512
May 201958108
Jun 201934162
Jul 201950162
Aug 201960145
Sep 201940165
Oct 201942143
Nov 201926143
Dec 201938140
Jan 202016120
Feb 202040154
Mar 202022177
Apr 202040161
May 2020592114
Jun 202047132
Jul 202035142
Aug 202035141
Sep 202097150
Oct 202025161
Nov 20201801
Dec 20205710
Jan 20214711
Feb 20214144
Mar 20212821
Apr 20212510
May 2021902
Jun 2021111
Aug 2021212
Sep 2021101
Oct 20214146
Nov 20213611
Dec 20214473
Jan 20224611
Feb 20224401
Mar 20223110
Apr 20223831
May 20226100
Jun 20229823
Jul 20224910
Aug 20225200
Sep 20224402
Oct 20227900
Nov 20221810
Dec 20221000
Jan 20233111
Feb 20234900
Mar 20235300
Apr 20234641
May 20233121
Jun 20234900
Jul 20236261
Aug 20233611
Sep 20234600
Oct 202310230
Nov 202320700
Dec 202310121
Jan 20242000
Feb 20242112
Mar 20244811
Apr 20244311
May 20245900
Jun 20248400
Jul 20242811
Aug 20242842
Sep 20242700
Total7339887668